Dionne
With the world reshaped by the Covid-19 pandemic and its accompanying health scares, the significance of Biotechnology Start-ups have never been more critical. It’s a new dawn for biotech innovators in Canada, particularly for those that bloomed amidst the pandemic. This article will highlight established start-ups in the biotech industry in London, England, since 2020.
Entrepreneurs have responded promptly to global health needs, providing new hopes in the journey to creating comprehensive solutions for various health issues and this has given rise to numerous promising biotech start-ups in London. Evidently, these start-ups reach beyond managing the present global health crisis to open new frontiers for the biotech industry.
Presented here are some of these remarkable start-ups that have leveraged advanced biotech to plough a new course in the industry, revolutionize healthcare, and redefine the path of future start-ups in the biotech industry. Their breakthroughs, discoveries, and unwavering commitment are undoubtedly reshaping the biotech landscape, lending a promising outlook to the future of healthcare globally.
Hoxton Farms
Founded by Ed Steele and Max Jamilly, Hoxton Farms grows animal fat without actual animals. It combines cell biology with mathematical modelling to cultivate fat as an ingredient for the meat alternatives industry. The London-based start-up emphasizes sustainability and health, engineering fat that matches the taste and texture of traditional meat. Hoxton Farms can also be found on LinkedIn and Twitter (@hoxtonfarms).
Dunad Therapeutics
Launched by Diana Kraskouskaya and Patrick T. Gunning, Dunad Therapeutics is a biopharmaceutical company specializing in developing next-generation targeted protein degradation therapies. Their cutting-edge approach holds great potential for curing cancer and other diseases by breaking them down at the molecular level.
Bactobio
Founded by Daniel Blicher Holst Hansen, Bactobio uses synthetic biology, next-generation sequencing and machine learning technologies to explore novel microbes for medical and industrial applications. Their initiatives to solve antibiotic resistance crisis by discovering new antibiotic classes for most urgent bacterial pathogens have made them a force to be reckoned within the biotech industry. They can also be found on LinkedIn and Twitter (@bactobio).
Purespring Therapeutics
Purespring Therapeutics, established by Moin Saleem, is a pioneer in AAV gene therapy with a specific focus on the kidney. They are one of the few global companies dedicated to renal gene therapies and are making significant strides in this specialized field. Purespring Therapeutics can also be connected with on LinkedIn and Twitter (@PURESPRINGTX).
Duke Street Bio
Duke Street Bio, founded in 2020, is a medical drug development company set on offering improved treatment to cancer patients. Specialized in biopharma, biotechnology, life science, and other medical fields, Duke Street Bio is committed to making revolutionary strides in their sector. They can also be found on LinkedIn.
Kuano
Co-founded by David Wright, Jarryl D’Oyley, Parminder Ruprah, and Vid Stojevic, Kuano delivers innovative quantum and AI solutions for drug discovery and design. Their discovery platform combines target quantum mapping and AI-led chemistry, promising faster development of better drug candidates. Kuano can also be found on LinkedIn and Twitter (@QuantumKuano).
Complement Therapeutics
Complement Therapeutics, is a preclinical stage company that focuses on developing a precision medicine diagnostic platform. This platform allows for patient stratification based on their complement-activation profile with potential to enable both patient selection and serve as an efficacy biomarker in future clinical studies. They can be found on LinkedIn.
ProtonDx
Focused on transforming molecular testing services, ProtonDx was founded by a trio of innovative leaders, Jesus Rodriguez Manzano, Nicolas Moser, and Pantelis Georgiou. The diagnostic platform developed by ProtonDx combines speed, sensitivity, specificity, and convenience to identify and differentiate multiple pathogens from a single sample. They can also be found on LinkedIn.
Digistain
Launched by Christopher Phillips and Hemmel Amrania, Digistain uses infrared scanning to help decide which breast cancer patients need chemotherapy. They’re taking complex diagnostics digital, offering precision decision-making for treatment plans. Digistain can be found on LinkedIn.
AccuStem Sciences
AccuStem Sciences is dedicated to optimizing outcomes for all patients with cancer. Their efforts involve substantial research that endeavours to bring innovative solutions to the field of oncology, reshaping the way cancer treatments are approached.
Inspira Pharmaceuticals
Inspira Pharmaceuticals, co-founded by Nick Woolf and Rory McGoldrick, is dedicated to researching and developing treatments for respiratory diseases. They strive to create cutting-edge technology for medicine and therapy development, and can be found on LinkedIn and Twitter (@Inspira_pharma).
These companies represent the future of the biotech industry, their innovative products and research opening new doors for scientific breakthroughs and potentially revolutionizing healthcare as we know it.